logo

For the Inventor, By the Inventor

Lafayette, CO, United States of America

Dharmacon, Inc.

Calculating rank
USPTO Granted Patents = 116

% Expired Patents = 63.8



Trademarks = 11

Forward Citations = 4,103

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Devin Leake (112 out of 135 patents)

silverMedal Anastasia Khvorova (111 out of 208 patents)

bronzeMedal William Marshall (107 out of 138 patents)

4.  Angela Reynolds (103 out of 126 patents)

5.  Stephen Scaringe (102 out of 123 patents)

6.  Steven Read (97 out of 118 patents)

7.  Barbara Robertson (6 out of 6 patents)

8.  Christina Yamada (5 out of 6 patents)

9.  Annaleen Vermeulen (4 out of 6 patents)

10.  Kathryn Robinson (3 out of 3 patents)

11.  Rob Kaiser (2 out of 5 patents)

12.  Emily Anderson (2 out of 3 patents)

13.  Joshua Stahl (1 out of 10 patents)

14.  Brady Culver (1 out of 7 patents)

15.  Abel Licon (1 out of 1 patent)


Core Competencies:
RNA Interference
siRNA
Gene Silencing
Oligonucleotides
Biotherapeutics
Gene Regulation
Polynucleotide Synthesis
Micro-RNA
Functional siRNA
Inhibitory RNA
CTGF
APOB

116 patents:

1. 12514868 - Multiplex shRNA for Use in Vectors (2026-01-06),
2. 9988625 - Templates, libraries, kits and methods for generating molecules (2018-06-05),
3. 8501706 - Duplex oligonucleotide complexes and methods for gene silencing by RNA interference (2013-08-06),
4. 8461326 - SiRNA targeting connective tissue growth factor (CTGF) (2013-06-11),
5. 8445668 - SiRNA targeting apolipoprotein (APOB) (2013-05-21),
6. 8445667 - SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) (2013-05-21),
7. 8426579 - SiRNA targeting myeloid differentiation primary response gene (88) (MYD88) (2013-04-23),
8. 8415466 - Duplex oligonucleotides with enhanced functionality in gene regulation (2013-04-09),
9. 8399654 - siRNA targeting catenin, Beat-1 (CTNNB1) (2013-03-19),
10. 8367318 - Screening of micro-RNA cluster inhibitor pools (2013-02-05),
11. 8314229 - siRNA targeting tie-2 (2012-11-20),
12. 8304528 - SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1) (2012-11-06),
13. 8293887 - SiRNA targeting beta secretase (BACE) (2012-10-23),
14. 8273722 - Enhanced biotherapeutic production using inhibitory RNA (2012-09-25),
15. 8268985 - siRNA targeting amyloid beta (A4) precursor protein (APP) (2012-09-18),
Company Overview
Dharmacon, Inc., based in Lafayette, Colorado, specializes in RNA interference technologies, focusing on the development and manufacturing of small interfering RNA (siRNA) and other oligonucleotides. The company is a leader in gene silencing and regulation, providing innovative solutions for researchers in the fields of biotherapeutics and gene regulation. With a commitment to advancing the understanding of RNA biology, Dharmacon supports a wide range of applications, from basic research to therapeutic development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

Dharmacon, Inc. USPTO Patent Assignee Logo
116 Patents

#2 in Lafayette, CO

#67 in Colorado

#3,331 in US

#6,855 in the World

Lafayette, CO (US)
Lafayette, CO, United States of America

Dharmacon, Inc.

Forward Citations = 4,103

25 inventors:

goldMedal Devin Leake (112 out of 135 patents)

silverMedal Anastasia Khvorova (111 out of 208 patents)

bronzeMedal William Marshall (107 out of 138 patents)

4.  Angela Reynolds (103 out of 126 patents)

5.  Stephen Scaringe (102 out of 123 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dharmacon, Inc.. Retrieved from https://idiyas.com/company/dharmacon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…